Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining irinotecan with gemcitabine in treating patients who have refractory advanced solid tumors.

Timeline

Start

2001-08

Primary completion

2003-05

Completion

2009-06

Drugs

Indications